The French pharma major has started a $15.50 per share cash tender offer for Emeryville, California-based Dynavax, which ...

In labs, water consumption and single-use plastics like pipette tips can contribute to environmental impact. Lab equipment ...

In the latest of a flurry of announcements ahead of the holiday period, CMS has revealed a new, voluntary access programme ...

The FDA has delivered a gift to Novo Nordisk ahead of the holiday season, with the prompt approval of an oral formulation of ...

The FDA’s emerging framework represents more than a regulatory update; it is a paradigm shift toward human-relevant, ...

People in life sciences companies understand how patents are crucial to their business, by setting competitive boundaries, ...

"Our goal in the LATIFY trial was to reinvigorate the immune response of patients with lung cancer whose tumours stopped ...

In a new pharmaphorum podcast, web editor Nicole Raleigh speaks with Tarek Samad, Lundbeck’s senior vice president and head ...

The Centers for Medicare & Medicaid Services (CMS) has proposed two more programmes in the Trump administration's efforts to ...

But the digital-first promise carried a blind spot: it solves for tasks, not emotions. Patients don’t start, stay on, or ...

It's notable that Ipsen has bolted on more than 20 early-stage programmes since 2020 as part of a push to become a major ...

The ACIP has been accused of cherry-picking data on side effects – attempting to perpetuate a debunked link between the shots ...